{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T10:36:33Z","timestamp":1777545393995,"version":"3.51.4"},"reference-count":34,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2008,4,1]],"date-time":"2008-04-01T00:00:00Z","timestamp":1207008000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2016,10,7]],"date-time":"2016-10-07T00:00:00Z","timestamp":1475798400000},"content-version":"vor","delay-in-days":3111,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Molecular Therapy"],"published-print":{"date-parts":[[2008,4]]},"DOI":"10.1038\/mt.2008.9","type":"journal-article","created":{"date-parts":[[2008,3,25]],"date-time":"2008-03-25T15:37:22Z","timestamp":1206459442000},"page":"649-656","source":"Crossref","is-referenced-by-count":143,"title":["Intraventricular Enzyme Replacement Improves Disease Phenotypes in a Mouse Model of Late Infantile Neuronal Ceroid Lipofuscinosis"],"prefix":"10.1016","volume":"16","author":[{"given":"Michael","family":"Chang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jonathan D","family":"Cooper","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David E","family":"Sleat","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Seng H","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"James C","family":"Dodge","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marco A","family":"Passini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peter","family":"Lobel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Beverly L","family":"Davidson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1038\/mt.2008.9_bib1","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1111\/j.1750-3639.2004.tb00499.x","article-title":"Current state of clinical and morphological features in human NCL","volume":"14","author":"Goebel","year":"2004","journal-title":"Brain Pathol"},{"key":"10.1038\/mt.2008.9_bib2","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1002\/ajmg.1320310606","article-title":"Batten disease: past, present, and future","volume":"5","author":"Rider","year":"1988","journal-title":"Am J Med Genet Suppl"},{"key":"10.1038\/mt.2008.9_bib3","doi-asserted-by":"crossref","first-page":"1802","DOI":"10.1126\/science.277.5333.1802","article-title":"Association of mutations in a lysosomal protein with classical late-infantile neuronal ceroid lipofuscinosis","volume":"277","author":"Sleat","year":"1997","journal-title":"Science"},{"key":"10.1038\/mt.2008.9_bib4","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1007\/s002340050427","article-title":"MRI of neuronal ceroid lipofuscinosis. II. Postmortem MRI and histopathological study of the brain in 16 cases of neuronal ceroid lipofuscinosis of juvenile or late infantile type","volume":"39","author":"Autti","year":"1997","journal-title":"Neuroradiology"},{"key":"10.1038\/mt.2008.9_bib5","doi-asserted-by":"crossref","first-page":"331","DOI":"10.3349\/ymj.2003.44.2.331","article-title":"A case of late infantile neuronal ceroid lipofuscinosis","volume":"44","author":"Lee","year":"2003","journal-title":"Yonsei Med J"},{"key":"10.1038\/mt.2008.9_bib6","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1016\/S0887-8994(96)00224-X","article-title":"Neuroradiological findings in classical late infantile neuronal ceroid-lipofuscinosis","volume":"15","author":"Petersen","year":"1996","journal-title":"Pediatr Neurol"},{"key":"10.1038\/mt.2008.9_bib7","doi-asserted-by":"crossref","first-page":"9117","DOI":"10.1523\/JNEUROSCI.2729-04.2004","article-title":"A mouse model of classical late-infantile neuronal ceroid lipofuscinosis based on targeted disruption of the CLN2 gene results in a loss of tripeptidyl-peptidase I activity and progressive neurodegeneration","volume":"24","author":"Sleat","year":"2004","journal-title":"J Neurosci"},{"key":"10.1038\/mt.2008.9_bib8","doi-asserted-by":"crossref","first-page":"1782","DOI":"10.1038\/sj.mt.6300249","article-title":"Timing of therapeutic intervention determines functional and survival outcomes in a mouse model of late infantile batten disease","volume":"15","author":"Cabrera-Salazar","year":"2007","journal-title":"Mol Ther"},{"key":"10.1038\/mt.2008.9_bib9","doi-asserted-by":"crossref","first-page":"1334","DOI":"10.1523\/JNEUROSCI.2676-05.2006","article-title":"Intracranial delivery of CLN2 reduces brain pathology in a mouse model of classical late infantile neuronal ceroid lipofuscinosis","volume":"26","author":"Passini","year":"2006","journal-title":"J Neurosci"},{"key":"10.1038\/mt.2008.9_bib10","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1038\/sj.mt.6300049","article-title":"Enhanced survival of the LINCL mouse following CLN2 gene transfer using the rh.10 rhesus macaque-derived adeno-associated virus vector","volume":"15","author":"Sondhi","year":"2007","journal-title":"Mol Ther"},{"key":"10.1038\/mt.2008.9_bib11","first-page":"132","article-title":"Recombinant human acid \u03b1-glucosidase enzyme therapy for infantile glycogen storage disease type II: results of a phase I\/II clinical trial","volume":"3","author":"Amalfitano","year":"2001","journal-title":"Genet Med"},{"key":"10.1038\/mt.2008.9_bib12","doi-asserted-by":"crossref","first-page":"1464","DOI":"10.1056\/NEJM199105233242104","article-title":"Replacement therapy for inherited enzyme deficiency\u2014macrophage-targeted glucocerebrosidase for Gaucher's disease","volume":"324","author":"Barton","year":"1991","journal-title":"N Engl J Med"},{"key":"10.1038\/mt.2008.9_bib13","doi-asserted-by":"crossref","first-page":"1913","DOI":"10.1073\/pnas.87.5.1913","article-title":"Therapeutic response to intravenous infusions of glucocerebrosidase in a patient with Gaucher disease","volume":"87","author":"Barton","year":"1990","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1038\/mt.2008.9_bib14","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1016\/j.jpeds.2004.03.018","article-title":"Enzyme replacement therapy in mucopolysaccharidosis VI (Maroteaux-Lamy syndrome)","volume":"144","author":"Harmatz","year":"2004","journal-title":"J Pediatr"},{"key":"10.1038\/mt.2008.9_bib15","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1056\/NEJM200101183440304","article-title":"Enzyme-replacement therapy in mucopolysaccharidosis I","volume":"344","author":"Kakkis","year":"2001","journal-title":"N Engl J Med"},{"key":"10.1038\/mt.2008.9_bib16","doi-asserted-by":"crossref","first-page":"2743","DOI":"10.1001\/jama.285.21.2743","article-title":"Enzyme replacement therapy in Fabry disease: a randomized controlled trial","volume":"285","author":"Schiffmann","year":"2001","journal-title":"JAMA"},{"key":"10.1038\/mt.2008.9_bib17","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1073\/pnas.76.1.481","article-title":"Modification of the blood-brain barrier: increased concentration and fate of enzymes entering the brain","volume":"76","author":"Barranger","year":"1979","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1038\/mt.2008.9_bib18","doi-asserted-by":"crossref","first-page":"5838","DOI":"10.1073\/pnas.78.9.5838","article-title":"Delivery of hexosaminidase A to the cerebrum after osmotic modification of the blood-brain barrier","volume":"78","author":"Neuwelt","year":"1981","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1038\/mt.2008.9_bib19","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/j.expneurol.2004.03.007","article-title":"VEGF disrupts the neonatal blood-brain barrier and increases life span after non-ablative BMT in a murine model of congenital neurodegeneration caused by a lysosomal enzyme deficiency","volume":"188","author":"Young","year":"2004","journal-title":"Exp Neurol"},{"key":"10.1038\/mt.2008.9_bib20","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1002\/ana.20444","article-title":"Convection perfusion of glucocerebrosidase for neuronopathic Gaucher's disease","volume":"57","author":"Lonser","year":"2005","journal-title":"Ann Neurol"},{"key":"10.1038\/mt.2008.9_bib21","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/j.ymgme.2004.07.003","article-title":"Intrathecal enzyme replacement therapy reduces lysosomal storage in the brain and meninges of the canine model of MPS I","volume":"83","author":"Kakkis","year":"2004","journal-title":"Mol Genet Metab"},{"key":"10.1038\/mt.2008.9_bib22","author":"Rasband","year":"1997","journal-title":"NUS National Institues of Health"},{"key":"10.1038\/mt.2008.9_bib23","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.ymgme.2006.12.012","article-title":"Intrathecal enzyme replacement therapy: successful treatment of brain disease via the cerebrospinal fluid","volume":"91","author":"Dickson","year":"2007","journal-title":"Mol Genet Metab"},{"key":"10.1038\/mt.2008.9_bib24","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1016\/j.nbd.2006.09.001","article-title":"Successive neuron loss in the thalamus and cortex in a mouse model of infantile neuronal ceroid lipofuscinosis","volume":"25","author":"Kielar","year":"2007","journal-title":"Neurobiol Dis"},{"key":"10.1038\/mt.2008.9_bib25","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.nbd.2005.01.025","article-title":"Glial activation spreads from specific cerebral foci and precedes neurodegeneration in presymptomatic ovine neuronal ceroid lipofuscinosis (CLN6)","volume":"20","author":"Oswald","year":"2005","journal-title":"Neurobiol Dis"},{"key":"10.1038\/mt.2008.9_bib26","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/j.brainres.2004.07.030","article-title":"Late onset neurodegeneration in the Cln3\u2013\/\u2013 mouse model of juvenile neuronal ceroid lipofuscinosis is preceded by low level glial activation","volume":"1023","author":"Pontikis","year":"2004","journal-title":"Brain Res"},{"key":"10.1038\/mt.2008.9_bib27","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1111\/j.1750-3639.2004.tb00077.x","article-title":"Hippocampal pathology in the human neuronal ceroid-lipofuscinoses: distinct patterns of storage deposition, neurodegeneration and glial activation","volume":"14","author":"Tyynel\u00e4","year":"2004","journal-title":"Brain Pathol"},{"key":"10.1038\/mt.2008.9_bib28","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1042\/bj3570049","article-title":"Production and characterization of recombinant human CLN2 protein for enzyme-replacement therapy in late infantile neuronal ceroid lipofuscinosis","volume":"357","author":"Lin","year":"2001","journal-title":"Biochem J"},{"key":"10.1038\/mt.2008.9_bib29","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1093\/clinchem\/46.7.1005","article-title":"Enzyme-based diagnosis of classical late infantile neuronal ceroid lipofuscinosis: comparison of tripeptidyl peptidase I and pepstatin-insensitive protease assays","volume":"46","author":"Sohar","year":"2000","journal-title":"Clin Chem"},{"key":"10.1038\/mt.2008.9_bib30","doi-asserted-by":"crossref","first-page":"1589","DOI":"10.1111\/j.1523-1755.2004.00924.x","article-title":"Enzyme therapy for Fabry disease: neutralizing antibodies toward agalsidase, \u03b1 and \u03b2","volume":"66","author":"Linthorst","year":"2004","journal-title":"Kidney Int"},{"key":"10.1038\/mt.2008.9_bib31","doi-asserted-by":"crossref","first-page":"1402","DOI":"10.1182\/blood.V82.5.1402.1402","article-title":"Antibody response in patients with Gaucher disease after repeated infusion with macrophage-targeted glucocerebrosidase","volume":"82","author":"Richards","year":"1993","journal-title":"Blood"},{"key":"10.1038\/mt.2008.9_bib32","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1073\/pnas.0305480101","article-title":"Successful induction of immune tolerance to enzyme replacement therapy in canine mucopolysaccharidosis I","volume":"101","author":"Kakkis","year":"2004","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1038\/mt.2008.9_bib33","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1023\/A:1022998010833","article-title":"Induction of tolerance to a recombinant human enzyme, acid \u03b1-glucosidase, in enzyme deficient knockout mice","volume":"12","author":"Raben","year":"2003","journal-title":"Transgenic Res"},{"key":"10.1038\/mt.2008.9_bib34","doi-asserted-by":"crossref","first-page":"9321","DOI":"10.1523\/JNEUROSCI.2936-05.2005","article-title":"Functional correction of CNS phenotypes in a lysosomal storage disease model using adeno-associated virus type 4 vectors","volume":"25","author":"Liu","year":"2005","journal-title":"J Neurosci"}],"container-title":["Molecular Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1525001616314459?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1525001616314459?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,5,3]],"date-time":"2020-05-03T11:46:15Z","timestamp":1588506375000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1525001616314459"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,4]]},"references-count":34,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2008,4]]}},"alternative-id":["S1525001616314459"],"URL":"https:\/\/doi.org\/10.1038\/mt.2008.9","relation":{},"ISSN":["1525-0016"],"issn-type":[{"value":"1525-0016","type":"print"}],"subject":[],"published":{"date-parts":[[2008,4]]}}}